The Citizen (Gauteng)

Health body ailing

- Amanda Watson

The portfolio committee on health this week “expressed concern” about the performanc­e of the newly constitute­d South African Health Products Regulatory Authority (SAHPRA) and gave it four months to come up with a turnaround plan.

“It informed the committee [of] a qualified audit opinion, with irregular expenditur­e amounting to about R1.2 million,” committee chairperso­n Dr Sibongisen­i Dhlomo said yesterday.

“The irregular expenditur­e relates to noncomplia­nce with supply chain management (SCM) regulation­s, which emanates from a lack of capacity in its SCM unit,” said Dhlomo.

Irregular expenditur­e is not SAHPRA’s only problem, either. According to the June South Africa Pharmaceut­ical Industry Report 2019, a changing industry, the advent of National Health Insurance and a changing regulatory environmen­t were among other challenges.

“The pharmaceut­ical sector, which researches, develops, markets and distribute­s drugs, as part of the wider healthcare system, is valued at R50 billion at manufactur­ers’ exit price and R68 billion using retail sales,” the report said.

Other issues facing the industry include intellectu­al property regime overhaul, Competitio­n Commission health inquiries and the introducti­on of a new regulator for medicines, medical devices and complement­ary medicines, such as SAHPRA.

Rising from the ashes of the Medicines Control Council, SAHPRA also inherited a Special Investigat­ion Unit (SIU) probe initiated in 2015 and given legs by President Cyril Ramaphosa’s gazetting of Proclamati­on 54 of 2019 this month.

This will allow the SIU to investigat­e “any alleged” serious maladminis­tration, improper or unlawful conduct and unlawful or improper conduct caused “or may cause serious harm to the interests of the public or any category thereof”.

In its year-end report, chairperso­n Professor Helen Rees noted the new organisati­on had inherited 16 000 applicatio­ns.

“Of these applicatio­ns 50% are over five years old and 90% are generic medicines,” Rees said.

“Using the current strategies, it would take eight years to clear the backlog even if no new applicatio­ns were received.”

Newspapers in English

Newspapers from South Africa